What_WP Happened_VBD to_TO the_DT Streptococci_NP :_: Overview_NN of_IN Taxonomic_NP and_CC Nomenclature_NP Changes_NP Since_IN the_DT division_NN of_IN the_DT Streptococcus_NP genus_NN into_IN enterococci_NP ,_, lactococci_NP ,_, and_CC streptococci_NNS in_IN 1984_CD ,_, many_JJ changes_NNS in_IN the_DT nomenclature_NN and_CC taxonomy_NN of_IN the_DT Streptococcus_NP genus_NN have_VBP taken_VBN place_NN ._SENT The_DT application_NN of_IN genetic_JJ comparisons_NNS has_VBZ improved_VBN the_DT proper_JJ classification_NN of_IN the_DT different_JJ species_NN ._SENT The_DT Lancefield_NP system_NN of_IN serogrouping_VBG the_DT streptococci_NNS by_IN the_DT expression_NN of_IN beta-hemolysis_NN on_IN blood_NN agar_NN plates_NNS is_VBZ still_RB very_RB useful_JJ for_IN the_DT identification_NN of_IN streptococci_NNS for_IN patient_JJ management_NN ._SENT The_DT Lancefield_NP grouping_NN system_NN cannot_MD be_VB used_VBN in_IN itself_PP for_IN accurate_JJ identification_NN of_IN specific_JJ beta-hemolytic_JJ species_NNS ,_, but_CC it_PP can_MD be_VB a_DT useful_JJ part_NN of_IN the_DT identification_NN procedure_NN ._SENT Except_IN for_IN identification_NN of_IN the_DT "_`` Streptococcus_NP bovis_NN group_NN "_'' of_IN species_NNS and_CC Streptococcus_NP suis_NP ,_, Lancefield_NP grouping_NN is_VBZ of_IN little_JJ value_NN in_IN identification_NN of_IN the_DT non-beta-hemolytic_JJ streptococci_NNS and_CC related_JJ genera_NNS ._SENT In_IN fact_NN ,_, identification_NN of_IN the_DT non-beta-hemolytic_JJ species_NN is_VBZ problematic_JJ for_IN conventional_JJ as_RB well_RB as_IN commercially_RB available_JJ identification_NN procedures_NNS ._SENT A_DT combination_NN of_IN conventional_JJ tests_NNS and_CC specific_JJ chromogenic_JJ tests_NNS suggested_VBN by_IN several_JJ investigators_NNS is_VBZ presented_VBN and_CC discussed_VBN ._SENT Tables_NNS are_VBP included_VBN that_DT suggest_VBP tests_NNS and_CC procedures_NNS to_TO guide_VB investigators_NNS attempting_VBG to_TO identify_VB all_PDT the_DT species_NN ._SENT The_DT purpose_NN of_IN this_DT communication_NN is_VBZ to_TO outline_VB the_DT changes_NNS in_IN taxonomy_NN and_CC nomenclature_NN of_IN the_DT Streptococcus_NP genus_NN that_WDT have_VBP occurred_VBN in_IN the_DT past_JJ 15_CD years_NNS ._SENT These_DT changes_NNS are_VBP the_DT result_NN of_IN the_DT application_NN of_IN DNA-DNA_NP reassociation_NN ,_, 16S_JJ rDNA_NN gene_NN sequencing_VBG ,_, and_CC other_JJ molecular_JJ techniques_NNS that_WDT help_VBP delineate_VB differences_NNS in_IN bacterial_JJ genera_NNS and_CC species_NNS ._SENT The_DT 1984_CD Bergey_NP 's_POS Manual_NP of_IN Systemic_NP Bacteriology_NP listed_VBD only_RB seven_CD genera_NNS of_IN faculatatively_RB anaerobic_JJ gram-positive_JJ cocci_NNS (_( GPC_NP )_) ;_: Aerococcus_NP ,_, Leuconostoc_NP ,_, Micrococcus_NP ,_, Pediococcus_NP ,_, Staphylococcus_NP ,_, Streptococcus_NP ,_, and_CC Stomatococcus_NP ._SENT At_IN present_NN there_EX are_VBP 17_CD different_JJ genera_NNS of_IN GPC_NP ._SENT The_DT discussion_NN is_VBZ limited_VBN to_TO the_DT Streptococcus_NP genus_NN and_CC closely_RB related_VBN GPC_NP that_WDT are_VBP catalase_NN negative_JJ and_CC display_NN chains_NNS in_IN the_DT Gram_NP stain_NN ._SENT Technically_RB ,_, Leuconostoc_NP bacteria_NNS fit_VBP into_IN this_DT category_NN ,_, but_CC discussions_NNS on_IN changes_NNS in_IN this_DT genus_NN are_VBP not_RB included_VBN ,_, because_IN iden-tification_NN procedures_NNS and_CC clinical_JJ relevance_NN of_IN the_DT leuconostocs_NNS can_MD be_VB found_VBN in_IN a_DT review_NN written_VBN in_IN 1995_CD ._SENT Shortly_RB before_IN the_DT publication_NN of_IN Bergey_NP 's_POS Manual_NP in_IN 1986_CD ,_, the_DT genus_NN Streptococcus_NN was_VBD split_VBN into_IN three_CD genera_NNS (_( Enterococcus_NP ,_, Lactococcus_NP ,_, and_CC Streptococcus_NP )_) ._SENT Changes_NNS in_IN the_DT Enterococcus_NP and_CC Lactococcus_NP genera_NNS are_VBP not_RB detailed_JJ ,_, but_CC some_DT changes_NNS are_VBP included_VBN to_TO explain_VB changes_NNS in_IN the_DT Streptococcus_NP genus_NN ._SENT Many_JJ new_JJ species_NNS of_IN streptococci_NNS have_VBP been_VBN added_VBN to_TO the_DT genus_NN ,_, and_CC six_CD new_JJ genera_NNS of_IN GPC_NP that_IN form_NN chains_NNS have_VBP been_VBN established_VBN (_( Abiotrophia_NP ,_, Granulicatella_NP ,_, Dolosicoccus_NP ,_, Facklamia_NP ,_, Globicatella_NP ,_, and_CC Ignavigranum_NP )_) ._SENT The_DT majority_NN of_IN these_DT genera_NNS were_VBD split_VBN off_IN the_DT Streptococcus_NP genus_NN by_IN genetic_JJ and_CC phenotypic_JJ information_NN ._SENT The_DT earliest_JJS attempt_NN at_IN differentiating_VBG the_DT streptococci_NNS was_VBD probably_RB made_VBN in_IN 1903_CD by_IN Shottmuller_NP ,_, who_WP used_VBD blood_NN agar_NN to_TO differentiate_VB strains_NNS that_WDT were_VBD beta-hemolytic_JJ from_IN those_DT that_WDT were_VBD not_RB ._SENT Before_IN 1933_CD ,_, fermentation_NN and_CC tolerance_NN tests_NNS were_VBD the_DT only_JJ tests_NNS used_VBN for_IN differentiating_VBG many_JJ of_IN the_DT streptococci_NNS ._SENT In_IN 1933_CD Lancefield_NP reported_VBD the_DT technique_NN of_IN demonstrating_VBG specific_JJ carbohydrate_NN "_`` group_NN "_'' antigens_NNS associated_VBN with_IN the_DT beta-hemolytic_JJ strains_NNS ._SENT In_IN 1937_CD ,_, Sherman_NP proposed_VBD a_DT scheme_NN for_IN placing_VBG the_DT streptococci_NNS into_IN four_CD categories_NNS ._SENT These_DT categories_NNS were_VBD organized_VBN by_IN hemolytic_JJ reaction_NN ,_, group_NN carbohydrate_NN antigens_NNS ,_, and_CC phenotypic_JJ tests_NNS (_( primarily_RB fermentation_NN and_CC tolerance_NN tests_NNS )_) ._SENT Sherman_NP 's_POS four_CD divisions_NNS were_VBD the_DT pyogenic_JJ division_NN ,_, the_DT viridans_NNS division_NN ,_, the_DT lactic_JJ division_NN ,_, and_CC the_DT enterococci_NN ._SENT The_DT pyogenic_JJ division_NN included_VBD the_DT beta-hemolytic_JJ strains_NNS with_IN defined_VBN group_NN antigens_NNS (_( A_NP ,_, B_NP ,_, C_NP ,_, E_NP ,_, F_NP ,_, and_CC G_NP )_) ._SENT This_DT division_NN of_IN the_DT streptococci_NNS is_VBZ not_RB appreciably_RB different_JJ from_IN that_IN of_IN today_NN 's_POS identification_NN systems_NNS based_VBN on_IN serogrouping_NN ._SENT Sherman_NP 's_POS viridans_NNS division_NN included_VBD streptococcal_JJ species_NNS that_WDT were_VBD not_RB beta-hemolytic_JJ ,_, were_VBD not_RB tolerant_JJ to_TO high-pH_NN growth_NN conditions_NNS ,_, were_VBD not_RB salt_NN tolerant_JJ ,_, and_CC did_VBD not_RB grow_VB at_IN 10C_NP ._SENT This_DT group_NN is_VBZ still_RB known_VBN today_NN as_IN the_DT viridans_NNS streptococci_NNS ,_, and_CC many_JJ more_JJR species_NNS have_VBP been_VBN added_VBN to_TO this_DT classification_NN ._SENT Sherman_NP 's_POS lactic_JJ division_NN included_VBD strains_NNS that_WDT were_VBD associated_VBN primarily_RB with_IN the_DT manufacture_NN of_IN dairy_NN products_NNS ._SENT They_PP were_VBD not_RB associated_VBN with_IN human_JJ infections_NNS ._SENT This_DT group_NN differed_VBD from_IN the_DT pyogenic_JJ group_NN by_IN not_RB being_VBG beta-hemolytic_JJ ,_, by_IN having_VBG the_DT capacity_NN to_TO grow_VB at_IN 10C_JJ but_CC not_RB at_IN 45C_JJ ,_, and_CC by_IN failing_VBG to_TO grow_VB in_IN broth_NN containing_VBG 6.5_CD %_NN NaCl_NP ._SENT Sherman_NP 's_POS lactic_JJ division_NN was_VBD reclassified_VBN as_IN the_DT Lactococcus_NP genus_NN in_IN the_DT mid-1980s_NNS ._SENT Lactococcus_NN species_NNS that_WDT have_VBP recently_RB been_VBN isolated_VBN from_IN human_JJ infections_NNS have_VBP phenotypic_JJ characteristics_NNS that_WDT are_VBP not_RB the_DT same_JJ as_IN those_DT described_VBN by_IN Sherman_NP ._SENT Sherman_NP 's_POS fourth_JJ division_NN was_VBD termed_VBN the_DT enterococci_NN and_CC included_VBD the_DT four_CD species_NNS known_VBN at_IN that_DT time_NN ._SENT Although_IN some_DT of_IN the_DT enterococci_NN were_VBD beta-hemolytic_JJ ,_, other_JJ characteristics_NNS such_JJ as_IN the_DT capacity_NN to_TO grow_VB in_IN broths_NNS at_IN high_JJ pH_NN ,_, high_JJ salt_NN concentrations_NNS ,_, and_CC a_DT wide_JJ temperature_NN range_NN (_( 10_CD to_TO 45C_NP )_) differentiated_VBD them_PP from_IN the_DT other_JJ three_CD divisions_NNS ._SENT The_DT number_NN of_IN Enterococcus_NP species_NN has_VBZ increased_VBN to_TO more_JJR than_IN 20_CD ._SENT All_DT of_IN the_DT new_JJ species_NNS have_VBP phenotypic_JJ characteristics_NNS similar_JJ to_TO those_DT described_VBN by_IN Sherman_NP ._SENT The_DT classification_NN and_CC identification_NN of_IN streptococci_NNS was_VBD severely_RB hampered_VBN by_IN a_DT hierarchical_JJ dichotomous_JJ approach_NN relying_VBG on_IN a_DT very_RB limited_JJ number_NN of_IN complex_JJ characters_NNS (_( colony_NN size_NN ,_, hemolysis_NNS ,_, and_CC group_NN carbohydrate_NN antigens_NNS )_) that_WDT resulted_VBD in_IN species_NN definitions_NNS that_WDT are_VBP often_RB qualified_VBN by_IN a_DT number_NN of_IN exceptions_NNS ._SENT Moreover_RB ,_, because_IN these_DT organisms_NNS grow_VBP slowly_RB and_CC may_MD require_VB additional_JJ factors_NNS for_IN isolation_NN and_CC characterization_NN ,_, as_RB well_RB as_IN the_DT somewhat_RB cumbersome_JJ classification_NN system_NN ,_, identification_NN of_IN streptococci_NNS to_TO the_DT species_NN level_NN is_VBZ rarely_RB performed_VBN in_IN time_NN to_TO be_VB relevant_JJ to_TO the_DT treatment_NN of_IN the_DT patient_NN from_IN whom_WP the_DT organism_NN was_VBD isolated_VBN ._SENT One_CD of_IN the_DT most_RBS useful_JJ tools_NNS applied_VBN to_TO the_DT revision_NN of_IN the_DT classification_NN system_NN for_IN the_DT Streptococcus_NP genus_NN is_VBZ the_DT application_NN of_IN 16S_JJ rRNA_NN gene_NN sequencing_NP ._SENT Figure_NN depicts_VBZ a_DT phylogenetic_JJ tree_NN of_IN the_DT currently_RB available_JJ sequences_NNS for_IN the_DT species_NN included_VBD in_IN the_DT Streptococcus_NP genus_NN ._SENT I_PP have_VBP chosen_VBN to_TO present_VB the_DT identification_NN schemes_NNS listed_VBN in_IN the_DT following_VBG tables_NNS based_VBN strictly_RB on_IN phenotypic_JJ characteristics_NNS because_IN I_PP feel_VBP that_IN the_DT clinical_JJ microbiologist_NN can_MD easily_RB place_VB the_DT species_NN into_IN groups_NNS that_WDT are_VBP phenotypically_RB related_VBN with_IN only_RB a_DT few_JJ microbiologic_JJ tests_NNS ._SENT These_DT phenotypic_JJ groups_NNS do_VBP not_RB necessarily_RB correlate_JJ with_IN the_DT groups_NNS shown_VBN in_IN the_DT genetic_JJ tree_NN in_IN Fig._NN ._SENT FIG._NN 1_CD ._SENT |_SYM Phylogenetic_JJ relationship_NN among_IN 55_CD Streptococcus_NP species_NNS based_VBN on_IN analysis_NN of_IN 16S_JJ rRNA_NN gene_NN sequences_NNS ._SENT Phylogenetic_JJ relationship_NN among_IN 55_CD Streptococcus_NP species_NNS based_VBN on_IN analysis_NN of_IN 16S_JJ rRNA_NN gene_NN sequences_NNS ._SENT The_DT dendrogram_NN was_VBD constructed_VBN by_IN the_DT clustal_JJ method_NN using_VBG the_DT DNASTAR_NP program_NN ._SENT The_DT units_NNS at_IN the_DT bottom_NN of_IN the_DT tree_NN indicate_VBP distance_NN between_IN sequence_NN pairs_NNS ._SENT HEMOLYTIC_NP STREPTOCOCCI_NP :_: For_IN clinical_JJ laboratories_NNS as_RB well_RB as_IN taxonomists_NNS ,_, one_CD of_IN the_DT most_RBS useful_JJ phenotypic_JJ characteristics_NNS of_IN streptococci_NNS is_VBZ the_DT reaction_NN of_IN the_DT bacteria_NNS on_IN blood_NN agar_NN plates_NNS ._SENT Hemolysis_NNS is_VBZ used_VBN as_IN a_DT guide_NN for_IN managing_VBG patients_NNS as_RB well_RB as_IN an_DT aid_NN in_IN classification_NN of_IN the_DT bacterium_NN to_TO the_DT species_NN level_NN ._SENT J._NP H._NP Brown_NP in_IN 1919_CD first_RB defined_VBN the_DT reactions_NNS of_IN streptococci_NNS on_IN blood_NN agar_NN plates_NNS ._SENT This_DT monograph_NN is_VBZ no_RB longer_RBR available_JJ ,_, but_CC Brown_NP 's_POS definitions_NNS are_VBP accurately_RB shown_VBN in_IN reference_NN ._SENT It_PP is_VBZ very_RB important_JJ that_IN clinical_JJ and_CC physician_NN office_NN laboratories_NNS accurately_RB identify_VBP the_DT beta-hemolytic_JJ reactions_NNS of_IN the_DT streptococci_NNS ._SENT Table_NN lists_VBZ all_DT beta-hemolytic_JJ streptococci_NNS known_VBN to_TO date_NN ._SENT There_EX is_VBZ one_CD exception_NN included_VBN in_IN this_DT table_NN ;_: S._NP dysgalactiae_NNS subsp_NN ._SENT dysgalactiae_NN is_VBZ not_RB beta-hemolytic_JJ but_CC is_VBZ included_VBN for_IN taxonomic_JJ reasons_NNS ._SENT Column_NN 1_CD in_IN Table_NP lists_VBZ all_PDT the_DT species_NN and_CC subspecies_NN of_IN beta-hemolytic_JJ streptococci_NNS ._SENT Column_NN 2_CD lists_NNS the_DT Lancefield_NP group_NN antigens_NNS that_WDT are_VBP associated_VBN with_IN each_DT species_NN ._SENT Columns_NNS 3_CD to_TO 12_CD list_NN 10_CD phenotypic_JJ characteristics_NNS that_WDT can_MD be_VB used_VBN to_TO help_VB identify_VB the_DT streptococci_NNS to_TO the_DT species_NN level_NN when_WRB hemolysis_NNS and_CC identification_NN of_IN group_NN carbohydrate_NN antigen_NN fail_VBP to_TO do_VB so_RB ._SENT The_DT last_JJ column_NN gives_VBZ the_DT most_RBS common_JJ natural_JJ host_NN of_IN the_DT species_NN ._SENT With_IN the_DT exception_NN of_IN S._NP dysgalactiae_NNS subsp_NN ._SENT dysgalactiae_NNS ,_, S._NP equi_NP subsp_NN ._SENT equi_NP ,_, and_CC two_CD recently_RB described_VBN species_NNS ,_, S._NP phocae_NNS and_CC S._NP didelphis_NP ,_, all_PDT the_DT species_NNS listed_VBN in_IN Table_NP have_VBP been_VBN isolated_VBN from_IN human_JJ infections_NNS ._SENT Table_NN was_VBD constructed_VBN based_VBN on_IN the_DT molecular_JJ and_CC phenotypic_JJ characteristics_NNS described_VBN by_IN Schleifer_NP and_CC Kilpper-Balz_NP ,_, Vandamme_NP et_FW al._FW ,_, Vieira_NP et_FW al._FW ,_, and_CC our_PP$ own_JJ unpublished_JJ results_NNS of_IN testing_VBG all_DT reference_NN strains_NNS for_IN each_DT of_IN the_DT species_NN ._SENT Investigators_NNS used_VBD a_DT variety_NN of_IN techniques_NNS including_VBG DNA-DNA_NP reassociation_NN ,_, 16S_NP rDNA_NP sequencing_NP ,_, whole-cell_NN protein_NN analysis_NN ,_, multilocus_NN enzyme_NN electrophoresis_NN ,_, and_CC phenotypic_JJ characteristics_NNS to_TO help_VB establish_VB the_DT species_NN and_CC subspecies_NN included_VBN in_IN this_DT table_NN ._SENT Streptococcus_NN pyogenes_NNS |_SYM S._NP pyogenes_NNS is_VBZ also_RB known_VBN as_IN beta-hemolytic_JJ group_NN A_DT streptococcus_NN or_CC Lancefield_NP 's_POS group_NN A_DT strep_NN (_( GAS_NP )_) ._SENT It_PP is_VBZ the_DT most_RBS pathogenic_JJ bacterium_NN in_IN the_DT genus_NN Streptococcus_NN ._SENT All_DT clinicians_NNS should_MD be_VB aware_JJ that_IN GAS_NP is_VBZ the_DT agent_NN that_WDT causes_VBZ bacterial_JJ pharyngitis_NN ,_, impetigo_NN ,_, and_CC a_DT host_NN of_IN other_JJ infections_NNS including_VBG severe_JJ invasive_JJ diseases_NNS ._SENT The_DT recent_JJ review_NN by_IN Cunningham_NP is_VBZ an_DT excellent_JJ source_NN of_IN information_NN for_IN interested_JJ investigators_NNS to_TO familiarize_VB themselves_PP with_IN the_DT severity_NN and_CC diversity_NN of_IN diseases_NNS caused_VBN by_IN this_DT bacterium_NN ._SENT The_DT major_JJ (_( but_CC not_RB exclusive_JJ )_) virulence_NN factor_NN associated_VBN with_IN GAS_NP is_VBZ the_DT M-protein_NP antigen_NN ._SENT This_DT surface_NN antigen_NN is_VBZ the_DT antigen_NN that_WDT allows_VBZ the_DT GAS_NN to_TO avoid_VB phagocytosis_NN and_CC to_TO survive_VB in_IN the_DT human_JJ host_NN ._SENT The_DT hypervariable_JJ N-terminal_JJ portion_NN of_IN this_DT protein_NN dictates_VBZ the_DT type_NN specificity_NN of_IN each_DT antigen_NN ._SENT Lancefield_NP prepared_VBD type-specific_JJ antisera_NN to_TO many_JJ of_IN these_DT antigens_NNS and_CC used_VBD the_DT antisera_NN in_IN a_DT capillary_JJ precipitin_NN test_NN to_TO subtype_NN the_DT GAS_NN ._SENT This_DT system_NN is_VBZ still_RB in_IN use_NN in_IN some_DT laboratories_NNS after_IN more_JJR than_IN 60_CD years_NNS ._SENT In_IN recent_JJ years_NNS ,_, an_DT alternative_JJ system_NN called_VBD emm_NNS typing_VBG has_VBZ been_VBN developed_VBN ,_, which_WDT uses_VBZ the_DT sequence_NN of_IN the_DT gene_NN that_WDT encodes_VBZ the_DT M-protein_NP hyperviable_JJ region_NN ._SENT Correlation_NN between_IN the_DT serologic_JJ and_CC emm_JJ typing_VBG systems_NNS is_VBZ very_RB good_JJ ,_, and_CC in_IN most_JJS cases_NNS the_DT emm_NN type_NN reflects_VBZ the_DT M-protein_NP serologic_JJ type_NN ._SENT The_DT emm_JJ typing_VBG system_NN can_MD be_VB accessed_VBN through_IN the_DT CDC_NP web_NN site_NN ._SENT Methods_NNS for_IN emm_NNS typing_VBG and_CC the_DT sequences_NNS of_IN more_JJR than_IN 120_CD emm-types_NNS of_IN GAS_NNS are_VBP described_VBN in_IN references_NNS and_CC ._SENT From_IN Table_NP the_DT reader_NN can_MD determine_VB that_IN S._NP pyogenes_NNS is_VBZ not_RB the_DT only_JJ Streptococcus_NN that_WDT may_MD possess_VB the_DT group_NN A_DT antigen_NN ._SENT The_DT true_JJ incidence_NN of_IN non-S_NP ._SENT pyogenes_NNS GAS_JJ strains_NNS found_VBN in_IN human_JJ infections_NNS is_VBZ unknown_JJ ,_, but_CC from_IN the_DT information_NN available_JJ to_TO us_PP at_IN the_DT Centers_NPS for_IN Disease_NP Control_NP and_CC Prevention_NP (_( CDC_NP )_) Streptococcus_NP laboratory_NN ,_, these_DT strains_NNS are_VBP not_RB common_JJ ._SENT More_JJR information_NN regarding_VBG the_DT two_CD species_NNS S._NP dysgalactiae_NNS subsp_NN ._SENT equisimilis_NP and_CC S._NP anginosus_NP is_VBZ given_VBN below_IN where_WRB these_DT two_CD species_NNS are_VBP discussed_VBN ._SENT S._NP pyogenes_NNS is_VBZ best_RBS identified_VBN by_IN demonstration_NN of_IN the_DT group_NN A_DT antigen_NN on_IN the_DT cell_NN ._SENT Presumptive_JJ identification_NN can_MD be_VB made_VBN by_IN bacitracin_NN susceptibility_NN or_CC pyrrolidonylarylamidase_NN activity_NN ._SENT S._NP pyogenes_NNS strains_NNS are_VBP the_DT only_JJ beta-hemolytic_JJ streptococci_NNS that_WDT are_VBP positive_JJ in_IN both_DT of_IN these_DT tests_NNS ._SENT Some_DT of_IN the_DT other_JJ beta-hemolytic_JJ streptococci_NNS can_MD also_RB be_VB positive_JJ in_IN one_CD or_CC the_DT other_JJ ,_, but_CC not_RB both_CC ,_, of_IN these_DT tests_NNS ;_: therefore_RB ,_, these_DT tests_NNS alone_RB are_VBP not_RB 100_CD %_NN specific_JJ for_IN S._NP pyogenes_NNS ._SENT Streptococcus_NN agalactiae_NNS |_SYM S._NP agalactiae_NNS ,_, or_CC Lancefield_NP 's_POS group_NN B_NN streptococcus_NN (_( GBS_NP )_) is_VBZ the_DT most_RBS common_JJ cause_NN of_IN neonatal_JJ sepsis_NN ._SENT Reference_NN is_VBZ an_DT excellent_JJ starting_VBG point_NN for_IN those_DT interested_JJ in_IN learning_VBG more_JJR about_IN the_DT epidemiology_NN and_CC types_NNS of_IN diseases_NNS caused_VBN by_IN this_DT organism_NN ._SENT Two_CD major_JJ avenues_NNS of_IN investigation_NN have_VBP been_VBN explored_VBN for_IN the_DT prevention_NN of_IN GBS_NP disease_NN :_: the_DT development_NN of_IN vaccines_NNS and_CC the_DT screening_VBG procedures_NNS for_IN the_DT presence_NN of_IN GBS_NNS in_IN anal_JJ ,_, cervical_JJ or_CC vaginal_JJ carriers_NNS and_CC subsequent_JJ antimicrobial_JJ management_NN ._SENT S._NP agalactiae_NNS is_VBZ the_DT only_JJ Streptococcus_NP species_NN that_WDT has_VBZ the_DT group_NN B_NN antigen_NN ._SENT Some_DT other_JJ streptococcal_JJ species_NNS have_VBP recently_RB been_VBN identified_VBN however_RB ,_, that_DT cross-react_NN with_IN commercial_JJ slide_NN agglutination_NN tests_NNS (_( see_VB the_DT discussion_NN of_IN S._NP porcinus_NN ,_, below_RB )_) ._SENT GBS_NNS can_MD also_RB be_VB presumptively_RB identified_VBN by_IN the_DT CAMP_NN and_CC hippurate_NN reactions_NNS ._SENT Together_RB with_IN the_DT unique_JJ hemolytic_JJ reaction_NN (_( very_RB small_JJ zone_NN of_IN lysis_NN )_) ,_, these_DT two_CD presumptive_JJ tests_NNS are_VBP very_RB accurate_JJ in_IN the_DT identification_NN ._SENT Streptococcus_NN dysgalactiae_NNS subsp_NN ._SENT dysgalactiae_NN |_SYM The_DT exact_JJ composition_NN of_IN the_DT taxon_NN Streptococcus_NN dysgalactiae_NNS has_VBZ been_VBN in_IN a_DT state_NN of_IN flux_NN for_IN the_DT past_JJ few_JJ years_NNS ._SENT S._NP dysgalactiae_NNS subsp_NN ._SENT dysgalactiae_NN is_VBZ the_DT only_JJ species_NN listed_VBN on_IN Table_NP that_WDT is_VBZ not_RB beta-hemolytic_JJ ._SENT This_DT species_NN is_VBZ included_VBN because_IN of_IN the_DT other_JJ subspecies_NN included_VBN in_IN this_DT discussion_NN ._SENT Isolation_NN of_IN this_DT bacterium_NN from_IN human_JJ infections_NNS has_VBZ not_RB been_VBN documented_VBN ._SENT The_DT organism_NN has_VBZ virulence_NN factors_NNS similar_JJ to_TO those_DT of_IN S._NP pyogenes_NNS ,_, including_VBG M-like_JJ proteins_NNS ._SENT Identification_NN by_IN determining_VBG the_DT characteristics_NNS in_IN Table_NP should_MD be_VB considered_VBN presumptive_JJ ._SENT Determining_VBG that_IN an_DT alpha-hemolytic_JJ streptococcus_NN has_VBZ group_NN C_NP antigen_NN is_VBZ insufficient_JJ for_IN identification_NN ;_: other_JJ non-beta-hemolytic_JJ streptococci_NNS ,_, e.g._FW ,_, viridans_NNS streptococal_JJ species_NNS ,_, may_MD also_RB have_VB group_NN C_NP antigen_NN ._SENT Additional_JJ phenotypic_JJ or_CC genetic_JJ characteristics_NNS should_MD be_VB used_VBN to_TO identify_VB this_DT bacterium_NN ._SENT Streptococcus_NN dysgalactiae_NNS subsp_NN ._SENT equisimilis_NN |_SYM S._NP dysgalactiae_NNS subsp_NN ._SENT equisimilis_NN is_VBZ the_DT revised_VBN taxonomic_JJ epithet_NN for_IN what_WP was_VBD previously_RB termed_VBN S._NP equisimilis_NP or_CC Lancefield_NP 's_POS group_NN C_NP Streptococcus_NP ._SENT Genetic_JJ investigations_NNS indicated_VBD that_IN Lancefield_NP 's_POS group_NN C_NP strain_NN (_( also_RB known_VBN as_IN group_NN C_NP human_JJ strain_NN or_CC S._NP equisimilis_NP )_) ,_, Lancefield_NP 's_POS group_NN G_NP and_CC L_NP strains_NNS ,_, and_CC the_DT species_NNS known_VBN as_IN S._NP dysgalactiae_NNS were_VBD all_RB genetically_RB similar_JJ and_CC should_MD be_VB included_VBN in_IN one_CD taxon_NN ._SENT Since_IN S._NP dysgalactiae_NNS was_VBD the_DT oldest_JJS officially_RB recognized_VBN species_NNS ,_, all_RB of_IN these_DT entities_NNS were_VBD placed_VBN in_IN the_DT S._NP dysgalactiae_NNS classification_NN ._SENT Later_JJR investigations_NNS indicated_VBD that_IN Lancefield_NP group_NN C_NP strain_NN (_( S._NP equisimilis_NP )_) and_CC Lancefield_NP 's_POS group_NN G_NP and_CC L_NP strains_NNS should_MD be_VB grouped_VBN into_IN one_CD category_NN and_CC that_IN S._NP dysgalactiae_NNS should_MD be_VB placed_VBN in_IN different_JJ category_NN ,_, thus_RB creating_VBG two_CD separate_JJ subspecies_NN ,_, S._NP dysgalactiae_NNS subsp_NN ._SENT dysgalactiae_NNS and_CC S._NP dysgalactiae_NNS subsp_NN ._SENT equisimilis_NNS ._SENT More_RBR recently_RB ,_, investigators_NNS have_VBP shown_VBN that_IN some_DT strains_NNS of_IN S._NP dysgalactiae_NNS subsp_NN ._SENT equisimilis_NNS possess_VBP the_DT group_NN A_DT antigen_NN ._SENT Group_NP A_NP ,_, C_NP ,_, G_NP ,_, and_CC L_NP S._NP dysgalactiae_NNS subsp_NN ._SENT equisimilis_NN strains_NNS are_VBP found_VBN in_IN human_JJ infections_NNS ._SENT The_DT true_JJ incidence_NN figures_NNS are_VBP difficult_JJ to_TO estimate_VB but_CC in_IN our_PP$ experience_NN at_IN the_DT CDC_NP ,_, group_NN C_NP and_CC G_NP strains_NNS are_VBP found_VBN much_RB more_RBR commonly_RB in_IN human_JJ infections_NNS than_IN are_VBP group_NN A_NP and_CC L_NP strains_NNS of_IN this_DT species_NN ._SENT Like_IN S._NP dysgalactiae_NNS subsp_NN ._SENT dysgalactiae_NNS ,_, the_DT strains_NNS possessing_VBG different_JJ group_NN antigens_NNS of_IN S._NP dysgalactiae_NNS subsp_NN ._SENT equisimilis_NNS also_RB have_VBP virulence_NN factors_NNS similar_JJ to_TO S._NP pyogenes_NNS ,_, including_VBG emm_JJ gene_NN homologs_NNS (_( see_VB the_DT CDC_NP web_NN site_NN above_JJ )_) ._SENT The_DT group_NN antigen_NN can_MD be_VB used_VBN only_RB as_IN an_DT aid_NN in_IN species_NN identification_NN ._SENT The_DT phenotypic_JJ tests_NNS in_IN Table_NP should_MD be_VB used_VBN ,_, together_RB with_IN hemolytic_JJ reaction_NN and_CC group_NN antigen_NN ,_, to_TO identify_VB the_DT species_NN possessing_VBG Lancefield_NP 's_POS group_NN C_NP antigen_NN ._SENT A_DT total_NN of_IN six_CD different_JJ beta-hemolytic_JJ streptococcal_JJ species_NNS or_CC subspecies_NN can_MD have_VB the_DT group_NN C_NP antigen_NN ._SENT Streptococcus_NN equi_NNS subsp_NN ._SENT equi_NN |_SYM Streptococcus_NP equi_NP subsp_NN ._SENT equi_NP is_VBZ a_DT beta-hemolytic_JJ group_NN C_NP Streptococcus_NP that_WDT causes_VBZ strangles_NN in_IN horses_NNS ._SENT To_TO my_PP$ knowledge_NN ,_, this_DT species_NN has_VBZ not_RB been_VBN isolated_VBN from_IN humans_NNS ._SENT S._NP equi_NP subsp_NN ._SENT equi_NP has_VBZ a_DT protein_NN that_WDT induces_VBZ opsonic_JJ antibodies_NNS in_IN horses_NNS and_CC is_VBZ thought_VBN to_TO be_VB involved_VBN in_IN the_DT organism_NN 's_POS virulence_NN ._SENT Identification_NN of_IN this_DT subspecies_NN is_VBZ based_VBN on_IN the_DT hemolytic_JJ reaction_NN ,_, demonstration_NN of_IN the_DT group_NN C_NP antigen_NN ,_, differences_NNS in_IN hydrolysis_NN of_IN esculin_NN and_CC starch_NN ,_, and_CC fermentation_NN of_IN sorbitol_NN and_CC trehalose_NN ._SENT Streptococcus_NN equi_NNS subsp_NN ._SENT zooepidemicus_NN |_SYM Unlike_IN S._NP equi_NP subsp_NN ._SENT equi_NP ,_, S._NP equi_NP subsp_NN ._SENT zooepidemicus_NN is_VBZ found_VBN in_IN human_JJ infections_NNS ._SENT Most_RBS recently_RB ,_, this_DT organism_NN was_VBD associated_VBN with_IN a_DT large_JJ outbreak_NN of_IN nephritis_NN in_IN Brazil_NP ._SENT The_DT publication_NN by_IN Nicholson_NP et_FW al._FW provides_VBZ references_NNS to_TO previous_JJ nephritis_NN outbreaks_NNS and_CC other_JJ infections_NNS caused_VBN by_IN this_DT bacterium_NN ._SENT Most_RBS human_JJ infections_NNS can_MD be_VB traced_VBN back_RB to_TO the_DT consumption_NN of_IN contaminated_JJ dairy_NN products_NNS ._SENT This_DT organism_NN is_VBZ a_DT frequent_JJ cause_NN of_IN bovine_JJ mastitis_NN ._SENT S._NP equi_NP subsp_NN ._SENT zooepidemicus_NN has_VBZ a_DT surface-exposed_JJ protein_NN (_( Szp_NP )_) that_WDT is_VBZ antigenically_RB variable_JJ ,_, stimulates_VBZ opsonic_JJ protective_JJ antibodies_NNS ,_, and_CC shares_NNS certain_JJ structural_JJ features_NNS with_IN the_DT S._NP pyogenes_NNS M_NP protein_NN ._SENT Although_IN this_DT protein_NN does_VBZ not_RB have_VB significant_JJ sequence_NN homology_NN to_TO the_DT M_NP protein_NN ,_, it_PP is_VBZ tempting_JJ to_TO speculate_VB that_IN Szp_NP also_RB plays_VBZ an_DT antiphagocytic_JJ role_NN ._SENT S._NP equi_NP subsp_NN ._SENT zooepidemicus_NN is_VBZ identified_VBN by_IN beta-hemolysis_NN ,_, group_NN C_NP antigen_NN presence_NN ,_, hydrolysis_NN of_IN esculin_NN (_( 70_CD %_NN of_IN strains_NNS )_) and_CC starch_NN ,_, fermentation_NN of_IN sorbitol_NN ,_, and_CC occasional_JJ fermentation_NN of_IN trehalose_NN ._SENT Streptococcus_NN canis_NNS |_SYM S._NP canis_NP is_VBZ an_DT organism_NN that_WDT was_VBD described_VBN in_IN 1986_CD as_IN having_VBG the_DT Lancefield_NP group_NN G_NP antigen_NN and_CC was_VBD isolated_VBN from_IN animals_NNS ,_, most_RBS frequently_RB dogs_NNS (_( hence_RB the_DT name_NN "_`` canis_NNS "_'' )_) ._SENT Extensive_JJ phenotypic_JJ testing_NN of_IN isolates_NNS from_IN dogs_NNS was_VBD described_VBN in_IN 1994_CD ,_, and_CC the_DT isolation_NN of_IN S._NP canis_NNS from_IN a_DT human_NN with_IN sepsis_NN was_VBD reported_VBN in_IN 1997_CD ._SENT It_PP is_VBZ not_RB possible_JJ to_TO estimate_VB how_WRB frequently_RB S._NP canis_NP is_VBZ isolated_VBN from_IN humans_NNS ,_, because_IN most_RBS clinical_JJ laboratories_NNS do_VBP not_RB perform_VB phenotypic_JJ tests_NNS on_IN group_NN G_NN streptococci_NNS other_JJ than_IN the_DT hemolytic_JJ reaction_NN and_CC group_NN determination_NN ._SENT The_DT phenotypic_JJ profile_NN given_VBN in_IN Table_NP for_IN the_DT identification_NN of_IN S._NP canis_NNS is_VBZ that_IN of_IN nonhuman_NN strains_NNS ._SENT It_PP is_VBZ not_RB known_VBN whether_IN human_JJ strains_NNS will_MD have_VB the_DT same_JJ phenotypic_JJ characteristics_NNS ._SENT Streptococcus_NN anginosus_NP Group_NP |_SYM None_NN of_IN the_DT beta-hemolytic_JJ streptococci_NNS has_VBZ caused_VBN more_JJR confusion_NN about_IN terminology_NN and_CC classification_NN than_IN the_DT group_NN of_IN organisms_NNS listed_VBN as_IN S._NP anginosus_NP ._SENT There_EX is_VBZ no_DT doubt_NN that_IN this_DT group_NN includes_VBZ three_CD distinct_JJ species_NNS and_CC more_JJR subspecies_NN ._SENT S._NP anginosus_NP ,_, S._NP constellatus_NN ,_, and_CC S._NP intermedius_NP were_VBD all_DT collectively_RB known_VBN as_IN either_DT S._NP anginosus_NP or_CC S._NP milleri_NP at_IN one_CD time_NN ._SENT The_DT problem_NN with_IN the_DT term_NN "_`` S._NP milleri_NP "_'' was_VBD that_IN it_PP was_VBD never_RB accepted_VBN by_IN the_DT taxonomist_NN as_IN a_DT confirmed_VBN taxonomic_JJ entity_NN ._SENT DNA-DNA_NP reassociation_NN studies_NNS clearly_RB show_VBP that_IN the_DT aforementioned_JJ species_NNS are_VBP distinct_JJ taxons_NNS ._SENT There_EX are_VBP beta-hemolytic_JJ strains_NNS of_IN each_DT of_IN the_DT three_CD species_NNS ,_, and_CC the_DT strains_NNS may_MD possess_VB one_CD of_IN four_CD different_JJ Lancefield_NP group_NN antigens_NNS or_CC no_DT group_NN antigen_NN ._SENT Adding_VBG to_TO the_DT confusion_NN is_VBZ the_DT fact_NN that_IN non-beta-hemolytic_JJ strains_NNS of_IN the_DT three_CD species_NNS are_VBP more_RBR common_JJ than_IN beta-hemolytic_JJ strains_NNS ._SENT Non-beta-hemolytic_JJ varieties_NNS of_IN each_DT of_IN the_DT three_CD species_NNS are_VBP grouped_VBN into_IN the_DT general_JJ classification_NN of_IN viridans_NNS streptococci_NNS ._SENT Whiley_NP et_FW al._FW have_VBP proposed_VBN an_DT identification_NN scheme_NN based_VBN on_IN degradation_NN of_IN chromogenic_JJ substrates_NNS for_IN the_DT differentiation_NN of_IN the_DT three_CD species_NNS ._SENT In_IN addition_NN ,_, although_IN these_DT authors_NNS state_VBP that_IN hemolysis_NNS and_CC group_NN antigens_NNS are_VBP of_IN little_JJ value_NN in_IN differentiation_NN of_IN the_DT species_NN ,_, more_JJR isolates_NNS of_IN S._NP constellatus_NN tend_VBP to_TO be_VB beta-hemolytic_JJ than_IN of_IN either_DT S._NP anginosus_NP or_CC S._NP intermedius_NP ._SENT Isolates_NNS of_IN S._NP intermedius_NP are_VBP rarely_RB beta-hemolytic_JJ ._SENT These_DT authors_NNS also_RB state_VBP that_IN there_EX tends_VBZ to_TO be_VB an_DT association_NN between_IN the_DT clinical_JJ sources_NNS and_CC the_DT three_CD species_NNS ._SENT S._NP anginosus_NP isolates_NNS are_VBP commonly_RB isolated_VBN from_IN urogenital_JJ and_CC gastrointestinal_JJ sources_NNS ,_, S._NP constellatus_NN is_VBZ often_RB isolated_VBN from_IN respiratory_JJ and_CC many_JJ other_JJ sources_NNS ,_, while_IN S._NP intermedius_NP strains_NNS are_VBP commonly_RB identified_VBN from_IN brain_NN and_CC liver_NN abscesses_NNS ._SENT The_DT distribution_NN of_IN the_DT group_NN antigens_NNS also_RB shows_VBZ some_DT association_NN with_IN the_DT species_NN ._SENT Isolates_NNS of_IN S._NP intermedius_NP rarely_RB have_VBP group_NN antigens_NNS ,_, while_IN isolates_NNS of_IN S._NP anginosus_NP and_CC S._NP constellatus_NN often_RB have_VBP group_NN F_NN ,_, C_NP ,_, A_NP ,_, and_CC G_NP antigens_NNS (_( in_IN order_NN of_IN frequency_NN )_) ._SENT Other_JJ investigators_NNS have_VBP also_RB found_VBN similar_JJ distributions_NNS of_IN the_DT three_CD species_NNS using_VBG Whiley_NP 's_POS scheme_NN and_CC DNA_NN reassociation_NN as_IN reference_NN identification_NN procedures_NNS ._SENT Very_RB little_RB is_VBZ known_VBN about_IN virulence_NN factors_NNS produced_VBN by_IN this_DT group_NN of_IN bacteria_NNS ._SENT Two_CD enzymes_NNS that_WDT may_MD be_VB considered_VBN virulence_NN factors_NNS are_VBP alpha-N-acetylneuramidase_NN (_( sialidase_NN )_) and_CC hyaluronidase_NN ;_: S._NP intermedius_NP produces_VBZ both_DT of_IN these_DT enzymes_NNS ,_, S._NP constellatus_NN produces_VBZ only_JJ hyaluronidase_NN ,_, and_CC S._NP anginosus_NP produces_VBZ neither_RB ._SENT The_DT production_NN of_IN these_DT enzymes_NNS is_VBZ part_NN of_IN the_DT identification_NN scheme_NN proposed_VBN by_IN Whiley_NP et_FW al._FW ._SENT Identification_NN of_IN the_DT beta-hemolytic_NN as_RB well_RB as_IN non-beta-hemolytic_JJ species_NNS are_VBP given_VBN in_IN Table_NP ._SENT Whiley_NP 's_POS scheme_NN is_VBZ considered_VBN a_DT standard_NN for_IN phenotypic_JJ identification_NN of_IN the_DT three_CD species_NNS and_CC potential_JJ subspecies_NN ._SENT Table_NN has_VBZ been_VBN constructed_VBN from_IN the_DT data_NNS presented_VBN in_IN references_NNS ,_, ,_, ,_, ,_, ,_, ,_, ,_, ,_, ,_, ,_, and_NP ._SENT The_DT hemolytic_JJ reaction_NN and_CC Lancefield_NP group_NN antigens_NNS that_WDT are_VBP commonly_RB associated_VBN with_IN the_DT three_CD species_NNS are_VBP also_RB included_VBN ._SENT Subspecies_NN are_VBP also_RB included_VBN ._SENT Column_NN 2_CD under_IN each_DT of_IN the_DT species_NNS listed_VBN in_IN Table_NP represents_VBZ the_DT original_JJ Whiley_NP description_NN of_IN the_DT species_NN ;_: column_NN 1_CD under_IN each_DT of_IN the_DT species_NN represents_VBZ a_DT beta-hemolytic_JJ variant_NN of_IN each_DT species_NN ;_: and_CC column_NN 3_CD represents_VBZ an_DT official_NN or_CC unofficial_JJ subspecies_NN designation_NN of_IN that_DT particular_JJ species_NN ._SENT This_DT table_NN should_MD be_VB used_VBN as_IN a_DT guide_NN for_IN identification_NN of_IN the_DT species_NN ,_, and_CC confirmation_NN of_IN subspecies_NN may_MD require_VB additional_JJ molecular_JJ documentation_NN ._SENT All_PDT the_DT species_NN and_CC subspecies_NN listed_VBN in_IN this_DT table_NN should_MD have_VB the_DT phenotypic_JJ characteristics_NNS of_IN the_DT S._NP anginosus_NN group_NN listed_VBN in_IN Table_NP ._SENT Column_NN 1_CD under_IN S._NP anginosus_NP is_VBZ the_DT description_NN of_IN the_DT group_NN of_IN strains_NNS identified_VBN but_CC not_RB proposed_VBN for_IN subspecies_NN status_NN by_IN Whiley_NP et_FW al._FW ._SENT Column_NN 3_CD under_IN S._NP anginosus_NP is_VBZ the_DT description_NN of_IN the_DT "_`` motile_JJ S._NP milleri_NNS "_'' strains_NNS ._SENT Additional_JJ variants_NNS of_IN S._NP anginosus_NNS have_VBP been_VBN described_VBN based_VBN on_IN ribotypes_NNS ,_, some_DT of_IN which_WDT correlate_VBP with_IN the_DT entities_NNS listed_VBN in_IN Table_NP ._SENT Commercial_JJ identification_NN systems_NNS that_WDT have_VBP three_CD of_IN the_DT seven_CD chromogenic_JJ substrates_NNS suggested_VBN by_IN Whiley_NP et_FW al._FW are_VBP available_JJ ._SENT The_DT Fluo-Card_NP Milleri_NP (_( Key_NP Scientific_NP ,_, Round_NP Rock_NP ,_, Tex._NP )_) includes_VBZ beta-d-fucosidase_NN ,_, beta-glucosidase_NN ,_, and_CC alpha-glucosidase_NN ._SENT Compared_VBN to_TO the_DT Whiley_NP scheme_NN ,_, this_DT system_NN identified_VBD 98_CD %_NN of_IN S._NP anginosus_NN strains_NNS ,_, 97_CD %_NN of_IN S._NP constellatus_NN strains_NNS ,_, and_CC 88_CD %_NN of_IN S._NP intermedius_NN strains_NNS ._SENT The_DT Rapid_NP ID-32_NP Strep_NP system_NN (_( Bio-Merieux_NP ,_, Marcy_NP l'Etoile_NP ,_, France_NP )_) (_( not_RB available_JJ for_IN clinical_JJ microbiology_NN use_NN in_IN the_DT United_NP States_NPS )_) includes_VBZ N-acetyl-beta-glucosaminidase_NN ,_, beta-glucosidase_NN ,_, and_CC beta-galactosidase_NN ._SENT These_DT authors_NNS did_VBD not_RB use_VB a_DT reference_NN method_NN to_TO compare_VB their_PP$ identification_NN ,_, and_CC so_RB all_DT 70_CD strains_NNS in_IN their_PP$ study_NN were_VBD placed_VBN into_IN one_CD of_IN the_DT three_CD species_NNS ._SENT Limia_NP et_FW al._FW evaluated_VBN the_DT Rapid_NP ID-32_NP Strep_NP system_NN as_RB well_RB as_IN the_DT Whiley_NP system_NN against_IN a_DT line_NN blot_NN hybridization_NN assay_NN ._SENT There_EX was_VBD an_DT 80_CD %_NN agreement_NN between_IN the_DT genotypic_JJ method_NN and_CC Whiley_NP 's_POS method_NN ._SENT The_DT agreement_NN between_IN the_DT genotypic_JJ method_NN and_CC the_DT Rapid_NP ID-32_NP Strep_NP system_NN was_VBD 76_CD %_NN ._SENT The_DT latter_JJ system_NN was_VBD particularly_RB inaccurate_JJ ,_, with_IN identification_NN of_IN only_RB 57_CD %_NN of_IN the_DT S._NP intermedius_NN strains_NNS ._SENT There_EX have_VBP been_VBN reports_NNS that_IN some_DT of_IN the_DT problems_NNS with_IN the_DT Rapid_NP ID-32_NP system_NN is_VBZ with_IN preparation_NN of_IN the_DT inoculum_NN density_NN and_CC growth_NN conditions_NNS ._SENT A_DT third_JJ commercial_JJ system_NN available_JJ for_IN identification_NN of_IN the_DT three_CD species_NNS is_VBZ the_DT Becton_NP Dickinson_NP Microbiology_NP Crystal_NP Gram-Positive_NP system_NN ._SENT This_DT system_NN has_VBZ beta-N-fucosidase_NN ,_, beta-glucosidase_NN ,_, and_CC alpha-glucosidase_NN ._SENT Very_RB little_JJ information_NN is_VBZ available_JJ about_IN the_DT utility_NN of_IN this_DT system_NN ._SENT Molecular_JJ technology_NN for_IN specific_JJ identification_NN of_IN these_DT species_NN has_VBZ been_VBN described_VBN ._SENT Pulsed-field_NP gel_NN electrophoresis_NN ,_, sequencing_VBG of_IN specific_JJ genes_NNS and_CC 16S_JJ rRNA_NN genes_NNS ,_, and_CC species-specific_JJ probes_NNS have_VBP all_RB been_VBN described_VBN ._SENT In_IN summary_NN ,_, we_PP know_VBP that_IN beta-hemolytic_JJ strains_NNS of_IN all_DT species_NNS have_VBP been_VBN isolated_VBN from_IN human_JJ infections_NNS (_( with_IN and_CC without_IN various_JJ Lancefield_NP antigens_NNS )_) ,_, but_CC we_PP know_VBP very_RB little_JJ about_IN the_DT incidence_NN and_CC clinical_JJ significance_NN of_IN each_DT of_IN the_DT redefined_JJ species_NN and_CC subspecies_NN ._SENT Streptococcus_NN constellatus_NN subsp_NN ._SENT pharyngis_NN |_SYM Whiley_NP et_FW al._FW have_VBP recently_RB described_VBN a_DT subspecies_NN of_IN S._NP constellatus_NN that_WDT is_VBZ beta-hemolytic_JJ and_CC carries_VBZ Lancefield_NP 's_POS group_NN C_NP antigen_NN ._SENT These_DT beta-hemolytic_JJ group_NN C_NP streptococci_NNS have_VBP a_DT predeliction_NN for_IN the_DT human_JJ throat_NN and_CC cause_NN pharyngitis_NN ._SENT Although_IN still_RB within_IN the_DT parameters_NNS of_IN the_DT criteria_NNS for_IN inclusion_NN in_IN the_DT species_NN ,_, the_DT DNA-DNA_NP reassociation_NN percentages_NNS are_VBP different_JJ for_IN the_DT subspecies_NN ._SENT Phenotypic_JJ differences_NNS in_IN the_DT chromogenic_JJ substrate_NN degradation_NN are_VBP also_RB different_JJ for_IN S._NP constellatus_NN subspp_NP ._SENT pharyngis_NNS and_CC constellatus_NN ._SENT A_DT second_JJ group_NN of_IN beta-hemolytic_JJ group_NN C_NP and_CC one_CD strain_NN of_IN group_NN G_NN streptococci_NNS were_VBD also_RB described_VBN in_IN this_DT report_NN but_CC not_RB formally_RB proposed_VBN as_IN a_DT subspecies_NN (_( see_VB column_NN 1_CD of_IN Table_NP under_IN S._NP anginosus_NP )_) ._SENT This_DT group_NN was_VBD closely_RB related_VBN to_TO S._NP anginosus_NP and_CC was_VBD not_RB necessarily_RB associated_VBN with_IN pharyngeal_JJ infections_NNS ._SENT The_DT reactions_NNS listed_VBN in_IN Table_NP in_IN column_NN 3_CD under_IN S._NP constellatus_NN subsp_NN ._SENT pharyngis_NN lists_VBZ the_DT tests_NNS to_TO identify_VB the_DT subspecies_NN ._SENT Streptococcus_NN porcinus_NNS |_SYM The_DT beta-hemolytic_JJ streptococci_NNS that_WDT carry_VBP Lancefield_NP group_NN E_NN ,_, P_NN ,_, U_NP ,_, and_CC V_CD and_CC four_CD new_JJ antigens_NNS were_VBD included_VBN in_IN a_DT description_NN of_IN S._NP porcinus_NN ._SENT S._NP porcinus_NN has_VBZ been_VBN isolated_VBN from_IN the_DT human_JJ genitourinary_JJ tracts_NNS of_IN female_JJ patients_NNS of_IN reproductive_JJ age_NN ._SENT The_DT incidence_NN and_CC the_DT importance_NN of_IN this_DT finding_NN are_VBP inconclusive_JJ and_CC are_VBP complicated_VBN by_IN the_DT fact_NN that_IN most_RBS human_JJ isolates_NNS of_IN S._NP porcinus_NNS react_VBP with_IN commercially_RB prepared_VBN GBS_NP grouping_NN antisera_NN ._SENT Slide_NN agglutination_NN group_NN B_NP reagent_NN has_VBZ also_RB been_VBN reported_VBN to_TO react_VB with_IN nonhuman_NN strains_NNS ._SENT Lancefield_NP extracts_VBZ of_IN these_DT strains_NNS generally_RB do_VBP not_RB react_VB with_IN CDC_NP group_NN B_NN antiserum_NN ._SENT Most_JJS strains_NNS isolated_VBN from_IN human_JJ sources_NNS react_VBP with_IN antiserum_NN prepared_VBN against_IN one_CD of_IN the_DT new_JJ group_NN antigens_NNS ._SENT Careful_JJ observation_NN of_IN the_DT hemolytic_JJ reaction_NN can_MD be_VB a_DT useful_JJ indicator_NN of_IN S._NP porcinus_NN ,_, and_CC clinical_JJ microbiologists_NNS should_MD be_VB aware_JJ of_IN the_DT potential_NN for_IN misidentification_NN of_IN these_DT isolates_NNS as_IN S._NP agalactiae_NNS ._SENT Typical_JJ strains_NNS of_IN S._NP agalactiae_NNS lyse_VBP red_JJ blood_NN cells_NNS weakly_RB ,_, and_CC colonies_NNS of_IN GBS_NNS are_VBP surrounded_VBN by_IN a_DT small_JJ zone_NN of_IN lysis_NN ._SENT On_IN the_DT other_JJ hand_NN ,_, typical_JJ strains_NNS of_IN S._NP porcinus_NNS lyse_VBP red_JJ blood_NN cells_NNS in_IN an_DT agar_NN plate_NN in_IN a_DT much_RB larger_JJR area_NN around_IN colony_NN growth_NN ._SENT Streptococcus_NN iniae_NNS |_SYM The_DT original_JJ cultures_NNS of_IN S._NP iniae_NNS were_VBD isolated_VBN from_IN freshwater_NN dolphins_NNS ._SENT S._NP iniae_NNS is_VBZ also_RB found_VBN in_IN aquacultures_NNS of_IN fish_NN and_CC can_MD be_VB transmitted_VBN to_TO humans_NNS via_IN the_DT fish_NN ._SENT An_DT outbreak_NN of_IN bacteremic_JJ disease_NN in_IN humans_NNS who_WP handle_VBP contaminated_JJ fish_NN has_VBZ been_VBN reported_VBN ,_, but_CC sporadic_JJ reports_NNS of_IN this_DT organism_NN have_VBP been_VBN rare_JJ at_IN the_DT CDC_NP ._SENT Beta-hemolytic_JJ streptococci_NNS without_IN group_NN antigen_NN should_MD be_VB tested_VBN for_IN the_DT phenotypic_JJ characteristics_NNS listed_VBN in_IN Table_NP for_IN definitive_JJ identification_NN ._SENT Streptococcus_NN phocae_NNS and_CC Streptococcus_NP didelphis_NP |_SYM As_RB noted_VBD above_RB ,_, S._NP phocae_NNS and_CC S._NP didelphis_NNS have_VBP not_RB been_VBN confirmed_VBN as_IN being_VBG isolated_VBN from_IN humans_NNS ._SENT S._NP phocae_NNS has_VBZ been_VBN isolated_VBN from_IN seals_NNS ,_, and_CC S._NP didelphis_NP has_VBZ been_VBN isolated_VBN from_IN opossums_NNS ._SENT The_DT data_NNS for_IN identification_NN of_IN these_DT two_CD beta-hemolytic_JJ streptococci_NNS were_VBD obtained_VBN from_IN these_DT published_VBN reports_NNS and_CC our_PP$ own_JJ testing_NN of_IN the_DT type_NN strains_NNS for_IN these_DT two_CD species_NNS ._SENT TABLE_NN 1_CD |_SYM Identification_NN of_IN the_DT beta-hemolytic_JJ streptococci_NNS TABLE_NP 2_CD |_SYM Identification_NN of_IN the_DT S._NP anginosus_NN group_NN BETA-HEMOLYTIC_NP STREPTOCOCCI_NP :_: As_RB stated_VBN above_RB ,_, the_DT determination_NN of_IN hemolysis_NNS is_VBZ one_CD of_IN the_DT most_RBS useful_JJ characteristics_NNS for_IN the_DT identification_NN of_IN streptococci_NNS ._SENT Nonhemolytic_JJ variants_NNS of_IN S._NP pyogenes_NNS ,_, S._NP agalactiae_NNS ,_, and_CC members_NNS of_IN the_DT S._NP anginosus_NN group_NN are_VBP well_RB documented_VBN ._SENT Whether_IN there_EX are_VBP nonhemolytic_JJ variants_NNS of_IN the_DT other_JJ streptococcal_JJ species_NNS that_WDT are_VBP normally_RB beta-hemolytic_JJ remains_VBZ to_TO be_VB determined_VBN ._SENT It_PP is_VBZ not_RB useful_JJ to_TO try_VB to_TO distinguish_VB between_IN alpha-hemolysis_NN and_CC no_DT hemolysis_NNS on_IN blood_NN agar_NN plates_NNS ._SENT The_DT composition_NN of_IN the_DT medium_NN including_VBG the_DT type_NN of_IN blood_NN and_CC incubation_NN atmospheres_NNS can_MD influence_VB whether_IN "_`` alpha_NN "_'' hemolysis_NNS occurs_VBZ ._SENT There_EX is_VBZ no_DT documented_VBN enzyme_NN or_CC toxin_NN that_WDT affects_VBZ red_JJ blood_NN cells_NNS to_TO produce_VB alpha-hemolysis_NN by_IN streptococci_NNS ._SENT The_DT greening_NN or_CC partial_JJ destruction_NN of_IN red_JJ blood_NN cells_NNS is_VBZ produced_VBN primarily_RB by_IN the_DT production_NN of_IN hydrogen_NN peroxide_NN by_IN the_DT streptococci_NNS ._SENT The_DT peroxide_NN destroys_VBZ some_DT of_IN the_DT red_JJ blood_NN cells_NNS and_CC releases_NNS hemoglobin_NN into_IN the_DT medium_NN surrounding_VBG the_DT streptococcal_JJ colony_NN that_WDT appears_VBZ green-like_JJ ._SENT If_IN oxygen_NN is_VBZ removed_VBN from_IN the_DT growth_NN atmosphere_NN ,_, peroxide_NN is_VBZ not_RB formed_VBN ,_, and_CC cultures_NNS that_WDT appeared_VBD "_`` alpha-hemolytic_NN "_'' will_MD be_VB nonhemolytic_JJ ._SENT The_DT value_NN of_IN identification_NN of_IN Lancefield_NP antigens_NNS on_IN non-beta-hemolytic_JJ streptococci_NNS is_VBZ also_RB limited_VBN ._SENT While_IN determination_NN of_IN the_DT group_NN D_NN antigen_NN for_IN identification_NN of_IN S._NP bovis_NN and_CC determination_NN of_IN group_NN R_NN or_CC other_JJ type_NN antigens_NNS for_IN S._NP suis_NNS are_VBP useful_JJ ,_, determination_NN of_IN Lancefield_NP antigens_NNS of_IN all_DT other_JJ non-beta-hemolytic_JJ streptococcal_JJ species_NNS ,_, including_VBG the_DT viridans_NNS streptococci_NNS ,_, is_VBZ of_IN very_RB little_JJ value_NN for_IN identification_NN ._SENT Streptococcus_NN pneumoniae_NNS |_SYM No_DT changes_NNS in_IN the_DT classification_NN have_VBP been_VBN made_VBN in_IN the_DT past_JJ few_JJ years_NNS for_IN S._NP pneumoniae_NNS ._SENT This_DT organism_NN is_VBZ still_RB the_DT leading_VBG cause_NN of_IN community-acquired_JJ pneumoniae_NNS ,_, and_CC the_DT increasing_VBG prevalence_NN of_IN multidrug_NN resistance_NN is_VBZ of_IN great_JJ concern_NN ._SENT Major_JJ developments_NNS in_IN the_DT formulation_NN of_IN vaccines_NNS for_IN adults_NNS and_CC children_NNS are_VBP encouraging_VBG for_IN control_NN of_IN pneumococcal_JJ infections_NNS ._SENT Isolation_NN and_CC identification_NN of_IN S._NP pneumoniae_NNS is_VBZ still_RB problematic_JJ since_IN conventional_JJ culture_NN techniques_NNS are_VBP far_RB from_IN perfect_JJ and_CC identification_NN of_IN some_DT strains_NNS is_VBZ refractory_JJ ._SENT Phenotypic_JJ physiologic_JJ tests_NNS place_VBP S._NP pneumoniae_NNS in_IN the_DT viridans_NNS Streptococcus_NP ,_, S._NP mitis_NN group_NN ._SENT Ideally_RB ,_, S._NP pneumoniae_NNS is_VBZ identified_VBN by_IN a_DT serologic_JJ technique_NN such_JJ as_IN omni_NN serum_NN or_CC a_DT slide_NN agglutination_NN test_NN or_CC typing_VBG serum_NN ._SENT Under_IN most_JJS circumstances_NNS ,_, if_IN serologic_JJ techniques_NNS are_VBP not_RB used_VBN ,_, identification_NN can_MD be_VB accomplished_VBN by_IN determining_VBG susceptibility_NN to_TO optochin_NN and/or_CC bile_NN solubility_NN ._SENT Recent_JJ molecular_JJ techniques_NNS ,_, such_JJ as_IN PCR_NP tests_NNS for_IN targeted_JJ proteins_NNS ,_, pneumolysin_NN ,_, and_CC penicillin_NN binding_VBG protein_NN genes_NNS ,_, have_VBP been_VBN shown_VBN to_TO improve_VB the_DT identification_NN of_IN culture-negative_JJ cases_NNS of_IN pneumonia_NN and_CC identification_NN of_IN strains_NNS ._SENT Streptococcus_NN bovis_NP Group_NP :_: S._NP bovis_NP ,_, S._NP equinus_NP ,_, S._NP gallolyticus_NP ,_, S._NP infantarius_NP ,_, S._NP pasteurianus_NP ,_, S._NP lutetiensis_NN |_SYM Table_NN lists_VBZ the_DT streptococcal_JJ species_NN included_VBN in_IN this_DT section_NN ._SENT DNA-DNA_NP reassociation_NN experiments_NNS have_VBP clarified_VBN the_DT taxonomic_JJ classification_NN of_IN this_DT group_NN of_IN streptococci_NNS ,_, but_CC the_DT nomenclature_NN of_IN these_DT species_NN is_VBZ confusing_JJ and_CC subject_JJ to_TO debate_VB ._SENT The_DT reasons_NNS for_IN the_DT changes_NNS listed_VBN in_IN Table_NP for_IN the_DT S._NP bovis_NN group_NN begin_VB with_IN a_DT report_NN published_VBN in_IN 1984_CD ._SENT These_DT investigators_NNS examined_VBD a_DT collection_NN of_IN strains_NNS ,_, most_JJS of_IN which_WDT were_VBD nonhuman_NN isolates_NNS ,_, and_CC reported_VBD that_IN the_DT phenotypically_RB described_VBN type_NN strains_NNS of_IN S._NP bovis_NP and_CC S._NP equinus_NN were_VBD a_DT single_JJ DNA_NN group_NN ,_, i.e._FW ,_, the_DT same_JJ species_NN ._SENT Farrow_NP et_FW al._FW identified_VBN seven_CD different_JJ DNA_NN groups_NNS in_IN their_PP$ study_NN ._SENT These_DT DNA_NP groups_NNS are_VBP referred_VBN to_TO throughout_IN this_DT section_NN ._SENT Other_JJ investigators_NNS performed_VBN DNA_NP reassociation_NN studies_NNS on_IN human_JJ isolates_NNS termed_VBD S._NP bovis_NP biotype_NN I_PP and_CC biotype_NN II_NP (_( the_DT latter_NN is_VBZ sometimes_RB referred_VBN to_TO as_IN S._NP bovis_NP variant_NN )_) and_CC discovered_VBD that_IN neither_DT biotype_NN I_PP nor_CC biotype_NN II_NP of_IN human_JJ origin_NN was_VBD sufficiently_RB closely_RB related_VBN to_TO the_DT reference_NN type_NN strains_NNS of_IN the_DT S._NP bovis-S_NNS ._SENT equinus_NP DNA_NP group_NN to_TO be_VB included_VBN in_IN the_DT newly_RB described_VBN species_NNS ._SENT These_DT investigators_NNS reported_VBD that_IN the_DT S._NP bovis_NN biotype_NN II_NP isolates_VBZ of_IN human_JJ origin_NN could_MD be_VB divided_VBN into_IN two_CD groups_NNS based_VBN on_IN phenotypic_JJ characteristics_NNS determined_VBN in_IN the_DT Rapid_JJ Strep_NN system_NN ._SENT These_DT two_CD groups_NNS were_VBD called_VBN S._NP bovis_NP II/1_NP and_CC S._NP bovis_NP II/2_NP ._SENT The_DT investigators_NNS also_RB reported_VBD that_IN the_DT human_JJ isolates_NNS of_IN S._NP bovis_NP II/2_NP were_VBD closely_RB related_VBN to_TO the_DT S._NP bovis_NN I_PP strains_VBZ by_IN DNA_NN reassociation_NN studies_NNS ._SENT Osawa_NP et_FW al._FW demonstrated_VBD that_IN strains_NNS isolated_VBN from_IN koalas_NNS ,_, dogs_NNS ,_, cows_NNS ,_, and_CC other_JJ animals_NNS belonged_VBD to_TO the_DT Farrow_NP et_FW al._FW DNA_NN group_NN 2_CD and_CC proposed_VBD that_IN these_DT strains_NNS be_VB called_VBN S._NP gallolyticus_NN based_VBN on_IN gallate-degrading_JJ capacity_NN ._SENT These_DT investigators_NNS also_RB included_VBD isolates_NNS of_IN S._NP bovis_NP I_NP and_CC II_NP from_IN human_JJ infections_NNS in_IN their_PP$ studies_NNS ._SENT The_DT human_JJ isolates_NNS of_IN S._NP bovis_NP I_NP and_CC II/2_NP joined_VBD the_DT S._NP gallolyticus_NN species_NNS based_VBN on_IN DNA_NP reassociation_NN studies_NNS ._SENT Further_JJR studies_NNS confirmed_VBD that_IN no_DT human_JJ strains_NNS called_VBD S._NP bovis_NNS by_IN current_JJ identification_NN procedures_NNS did_VBD in_IN fact_NN join_VB the_DT S._NP bovis-S_NNS ._SENT equinus_NN group_NN described_VBN by_IN Farrow_NP et_FW al._FW ._SENT All_PDT the_DT human_JJ isolates_NNS of_IN S._NP bovis_NP I_NP and_CC II/2_NP were_VBD suggested_VBN to_TO be_VB officially_RB identified_VBN as_IN S._NP gallolyticus_NN ._SENT These_DT experiments_NNS were_VBD done_VBN primarily_RB by_IN whole-cell_NN protein_NN analysis_NN ,_, which_WDT correlates_VBZ with_IN DNA_NP reassoci_NP 